Publications

Export 20 results:
Auteur Title [ Type(Asc)] Année
Filtres: Auteur is Caravaggio, Fernando  [Enlever les filtres]
Journal Article
Chung JKu, Nakajima S, Plitman E, Iwata Y, Uy D, Gerretsen P, Caravaggio F, Chakravarty MM, Graff-Guerrero A.  2016.  Β-Amyloid Burden is Not Associated with Cognitive Impairment in Schizophrenia: A Systematic Review.. Am J Geriatr Psychiatry. 24(10):923-39.
Caravaggio F, Plavén-Sigray P, Matheson GJames, Plitman E, Chakravarty MM, Borg J, Graff-Guerrero A, Cervenka S.  2018.  Trait impulsivity is not related to post-commissural putamen volumes: A replication study in healthy men.. PLoS One. 13(12):e0209584.
Caravaggio F, Plitman E, Chung JKu, Gerretsen P, Kim J, Iwata Y, Chakravarty MM, Remington G, Graff-Guerrero A.  2017.  Trait impulsiveness is related to smaller post-commissural putamen volumes in males but not females.. Eur J Neurosci. 46(7):2253-2264.
[Anonymous].  2020.  Structural Brain Differences Between Cognitively Impaired Patients With and Without Apathy.. Am J Geriatr Psychiatry.
Plitman E, Chavez S, Nakajima S, Iwata Y, Chung JKu, Caravaggio F, Kim J, Alshehri Y, Chakravarty MM, De Luca V et al..  2018.  Striatal neurometabolite levels in patients with schizophrenia undergoing long-term antipsychotic treatment: A proton magnetic resonance spectroscopy and reliability study.. Psychiatry Res Neuroimaging. 273:16-24.
Caravaggio F, Chung JKu, Plitman E, Boileau I, Gerretsen P, Kim J, Iwata Y, Patel R, Chakravarty MM, Remington G et al..  2017.  The relationship between subcortical brain volume and striatal dopamine D2/3 receptor availability in healthy humans assessed with [(11) C]-raclopride and [(11) C]-(+)-PHNO PET.. Hum Brain Mapp. 38(11):5519-5534.
Kim J, Plitman E, Iwata Y, Nakajima S, Mar W, Patel R, Chavez S, Chung JKu, Caravaggio F, Chakravarty MM et al..  2019.  Neuroanatomical profiles of treatment-resistance in patients with schizophrenia spectrum disorders.. Prog Neuropsychopharmacol Biol Psychiatry. :109839.
Chung JKu, Plitman E, Nakajima S, Chow TW, Chakravarty MM, Caravaggio F, Gerretsen P, Brown EE, Iwata Y, Mulsant BH et al..  2016.  Lifetime History of Depression Predicts Increased Amyloid-β Accumulation in Patients with Mild Cognitive Impairment.. J Alzheimers Dis. 49(4):1189-90.
Chung JKu, Plitman E, Nakajima S, Chow TW, Chakravarty MM, Caravaggio F, Gerretsen P, Brown EE, Iwata Y, Mulsant BH et al..  2015.  Lifetime History of Depression Predicts Increased Amyloid-β Accumulation in Patients with Mild Cognitive Impairment.. J Alzheimers Dis. 45(3):907-19.
Plitman E, Iwata Y, Caravaggio F, Nakajima S, Chung JKu, Gerretsen P, Kim J, Takeuchi H, Chakravarty MM, Remington G et al..  2017.  Kynurenic Acid in Schizophrenia: A Systematic Review and Meta-analysis.. Schizophr Bull.
Caravaggio F, Gerretsen P, Mar W, Chung JKu, Plitman E, Nakajima S, Kim J, Iwata Y, Patel R, Chakravarty MM et al..  2017.  Intranasal oxytocin does not modulate jumping to conclusions in schizophrenia: Potential interactions with caudate volume and baseline social functioning.. Psychoneuroendocrinology. 81:80-87.
Chung JKu, Plitman E, Nakajima S, Caravaggio F, Iwata Y, Gerretsen P, Kim J, Takeuchi H, Shinagawa S, Patel R et al..  2017.  Hippocampal and Clinical Trajectories of Mild Cognitive Impairment with Suspected Non-Alzheimer's Disease Pathology.. J Alzheimers Dis. 58(3):747-762.
Shah P, Plitman E, Iwata Y, Kim J, Nakajima S, Chan N, Brown EE, Caravaggio F, Torres E, Hahn M et al..  2020.  Glutamatergic neurometabolites and cortical thickness in treatment-resistant schizophrenia: Implications for glutamate-mediated excitotoxicity.. J Psychiatr Res. 124:151-158.
Plitman E, Nakajima S, de la Fuente-Sandoval C, Gerretsen P, Chakravarty MM, Kobylianskii J, Chung JKu, Caravaggio F, Iwata Y, Remington G et al..  2014.  Glutamate-mediated excitotoxicity in schizophrenia: a review.. Eur Neuropsychopharmacol. 24(10):1591-605.
Chung JKu, Plitman E, Nakajima S, Caravaggio F, Shinagawa S, Iwata Y, Gerretsen P, Kim J, Takeuchi H, Patel R et al..  2017.  The Effects of Cortical Hypometabolism and Hippocampal Atrophy on Clinical Trajectories in Mild Cognitive Impairment with Suspected Non-Alzheimer's Pathology: A Brief Report.. J Alzheimers Dis. 60(2):341-347.
Chung JKu, Plitman E, Nakajima S, Chakravarty MM, Caravaggio F, Takeuchi H, Gerretsen P, Iwata Y, Patel R, Mulsant BH et al..  2016.  Depressive Symptoms and Small Hippocampal Volume Accelerate the Progression to Dementia from Mild Cognitive Impairment.. J Alzheimers Dis. 49(3):743-54.
Chung JKu, Plitman E, Nakajima S, Chakravarty MM, Caravaggio F, Gerretsen P, Iwata Y, Graff-Guerrero A.  2016.  Cortical Amyloid β Deposition and Current Depressive Symptoms in Alzheimer Disease and Mild Cognitive Impairment.. J Geriatr Psychiatry Neurol. 29(3):149-59.
Chung JKu, Nakajima S, Shinagawa S, Plitman E, Chakravarty MM, Iwata Y, Caravaggio F, Pollock BG, Gerretsen P, Graff-Guerrero A.  2016.  Benzodiazepine Use Attenuates Cortical β-Amyloid and is Not Associated with Progressive Cognitive Decline in Nondemented Elderly Adults: A Pilot Study Using F(18)-Florbetapir Positron Emission Tomography.. Am J Geriatr Psychiatry. 24(11):1028-1039.
Burrer A, Caravaggio F, Manoliu A, Plitman E, Gütter K, Habermeyer B, Stämpfli P, Abivardi A, Schmidt A, Borgwardt S et al..  2020.  Apathy is not associated with reduced ventral striatal volume in patients with schizophrenia.. Schizophr Res.
Caravaggio F, Fervaha G, Iwata Y, Plitman E, Chung JKu, Nakajima S, Mar W, Gerretsen P, Kim J, Chakravarty MM et al..  2018.  Amotivation is associated with smaller ventral striatum volumes in older patients with schizophrenia.. Int J Geriatr Psychiatry. 33(3):523-530.